Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Hemostemix Inc
V.HEM
Alternate Symbol(s):
HMTXF
Healthcare
Biotechnology
Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated...
cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (TSXV:HEM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1)
•••
cndinvest
X
Comment by
cndinvest
on Nov 28, 2025 10:57am
RE:HEM
Why do you write that? Can you point specifically to lies he has expressed?
(83)
•••
valiantaffair
X
Post by
valiantaffair
on Nov 26, 2025 3:18pm
HEM
What a JOKE this company is. Thomas Smeek is nothing but a LIAR
Initial Assay Results From the First Five Holes of the 2025 Drilling Program
posted Dec 10, 2025 9:00am by
Viridian Metals Inc.
-
|
Several holes returned >20-metre mineralized intervals, including local high-grade copper zones such as 1.38% Cu (2.14% CuEq¹) over 0.7 metres from 4.45 metres depth. These strong early results reinforce Kraken as one of the shallowest and most laterally extensive magmatic sulphide systems in Canada ...read more
(26)
•••
digital130
X
Post by
digital130
on Oct 23, 2025 10:04pm
Fluff vs reality
You talked about sales 6 months ago and yet you haven't had one press release related to sales. Where your money going?
(26)
•••
digital130
X
Post by
digital130
on Aug 05, 2025 10:32pm
Inconsistent
Messages, trading, financing options. The timing is closer. one to watch
(17)
•••
KevinOleary
X
Comment by
KevinOleary
on Apr 05, 2025 1:47pm
RE:Vascular Dementia Phase one begins.. with NASDAQ AI Company
Amazing find. It matches the nr the company put out that everyone read on 3/6/25.
(2)
•••
loaddumper
X
Post by
loaddumper
on Mar 06, 2025 8:41am
Vascular Dementia Phase one begins.. with NASDAQ AI Company
https://www.newsfilecorp.com/release/243458
(407)
•••
Peladawn
X
Comment by
Peladawn
on Mar 02, 2025 3:43pm
RE:It’s alive!
Wow....looks like it's falling back into the ashes, huh, EMENEMENIMROD?
(407)
•••
Peladawn
X
Comment by
Peladawn
on Mar 02, 2025 3:26pm
RE:RE:They should be at 90%
Hey Fox.....judging by the fact you haven't been pumping HEM now for the last couple years, my guess is you bought in at about .20 and then pumped it until it bled out to about .05 in 2024 and
...more
(196)
•••
Donwaan
X
Post by
Donwaan
on Feb 19, 2025 4:49pm
Moonshot.
HEM seems to be coming back to earth. No reaching the moon just yet.
(1)
•••
SEAGEBE
X
Comment by
SEAGEBE
on Jan 19, 2025 2:24pm
RE:My take on these recent developments.......
Couldn't agree more! Exciting times ahead!
(2)
•••
loaddumper
X
Post by
loaddumper
on Jan 13, 2025 9:25am
news
https://www.newsfilecorp.com/release/236953/Hemostemix-Settlement-via-Depository-Trust-Company-Plus-OTCQB-Update?k=hemostemix
(2)
•••
loaddumper
X
Post by
loaddumper
on Jan 10, 2025 6:23pm
My take on these recent developments.......
Thomas is adding technical expertise through the Cytoimmune agreement that will assist in automating the manufacturing process allowing them to dramatically ramp production. Additionally, the amended
...more
(4)
•••
ENEMENEMYNEMO
X
Post by
ENEMENEMYNEMO
on Jan 09, 2025 11:16am
It’s alive!
Wow. Rising from the ashes!
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 31, 2024 4:05pm
New Press Release - Hemostemix Announces the First Tranche Closing of $1.8M of Its Recently Announced Private Placement
Calgary, Alberta--(Newsfile Corp. - October 31, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce it has closed its first tranche of the private placement of units ("Units"), as announced on October 11, 2024, for gross proceeds of ...
read article.
(83)
•••
cmarketinsights
X
Post by
cmarketinsights
on Oct 22, 2024 2:22pm
Hemostemix led last week’s top performers with a 50% gain
Hemostemix led last week’s top performers with a 50% gain. As highlighted last week, HEM is actively pursuing a $4M equity financing. The company is making significant strides with
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Lode Gold Enters into Exclusive LOI with a Mining Company to Advance Fremont Gold Project